SAFETY AND TOLERABILITY The safety profile of semaglutide in ESSENCE was consistent with its known profile from T2DM and obesity trials [10,12]
These include cases involving women, individuals with severe liver disease, or those who have known hypersensitivity to the drug
If Rybelsus is added to existing treatment with insulin or a sulfonylurea, a reduction in the dose of these medications should be considered to reduce the risk of hypoglycaemia
Dehydration can cause fatigue, dizziness, and difficulty concentrating
A 503B pharmacy following strict USP guidelines is being appropriately conservative
In addition, multiple 20242025 studies found that semaglutide users may have a higher risk of developing a specific eye condition called nonarteritic anterior ischemic optic neuropathy (NAION)